Wells Fargo & Company X Biotech Inc. Call Options Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XBIT
# of Institutions
52Shares Held
4.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$3.65 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$3.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA455KShares$1.46 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny281KShares$904,8810.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL254KShares$817,1390.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $98M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...